Page last updated: 2024-08-26

imipenem, anhydrous and Carcinoma, Non-Small Cell Lung

imipenem, anhydrous has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khalimov, ID; Krasin, VV; Latypov, AG; Potanin, AV; Potanin, VP; Sigal, EI; Sigal, RI; Taziev, RM1

Other Studies

1 other study(ies) available for imipenem, anhydrous and Carcinoma, Non-Small Cell Lung

ArticleYear
[Thienam treatment in early postoperative period after pneumonectomy in patients with lung cancer].
    Khirurgiia, 2001, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Postoperative Care; Postoperative Complications; Time Factors

2001